Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial.

Foeldvari I, Constantin T, Vojinović J, Horneff G, Chasnyk V, Dehoorne J, Panaviene V, Sušić G, Stanevicha V, Kobusinska K, Zuber Z, Dobrzyniecka B, Nikishina I, Bader-Meunier B, Breda L, Doležalová P, Job-Deslandre C, Rumba-Rozenfelde I, Wulffraat N, Pedersen RD, Bukowski JF, Vlahos B, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Arthritis Res Ther. 2019 May 23;21(1):125. doi: 10.1186/s13075-019-1916-9.

2.

Reversibility of peripheral blood leukocyte phenotypic and functional changes after exposure to and withdrawal from tofacitinib, a Janus kinase inhibitor, in healthy volunteers.

Weinhold KJ, Bukowski JF, Brennan TV, Noveck RJ, Staats JS, Lin L, Stempora L, Hammond C, Wouters A, Mojcik CF, Cheng J, Collinge M, Jesson MI, Hazra A, Biswas P, Lan S, Clark JD, Hodge JA.

Clin Immunol. 2018 Jun;191:10-20. doi: 10.1016/j.clim.2018.03.002. Epub 2018 Mar 5.

3.

Evaluation of the change in structural radiographic sacroiliac joint damage after 2 years of etanercept therapy (EMBARK trial) in comparison to a contemporary control cohort (DESIR cohort) in recent onset axial spondyloarthritis.

Dougados M, Maksymowych WP, Landewé RBM, Moltó A, Claudepierre P, de Hooge M, Lambert RG, Bonin R, Bukowski JF, Jones HE, Logeart I, Pedersen R, Szumski A, Vlahos B, van der Heijde D.

Ann Rheum Dis. 2018 Feb;77(2):221-227. doi: 10.1136/annrheumdis-2017-212008. Epub 2017 Sep 29.

4.

Modification of structural lesions on MRI of the sacroiliac joints by etanercept in the EMBARK trial: a 12-week randomised placebo-controlled trial in patients with non-radiographic axial spondyloarthritis.

Maksymowych WP, Wichuk S, Dougados M, Jones HE, Pedersen R, Szumski A, Marshall L, Bukowski JF, Lambert RG.

Ann Rheum Dis. 2018 Jan;77(1):78-84. doi: 10.1136/annrheumdis-2017-211605. Epub 2017 Sep 29.

5.

MRI evidence of structural changes in the sacroiliac joints of patients with non-radiographic axial spondyloarthritis even in the absence of MRI inflammation.

Maksymowych WP, Wichuk S, Dougados M, Jones H, Szumski A, Bukowski JF, Marshall L, Lambert RG.

Arthritis Res Ther. 2017 Jun 6;19(1):126. doi: 10.1186/s13075-017-1342-9.

6.

Effects of Long-Term Etanercept Treatment on Clinical Outcomes and Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: 104-Week Results From a Randomized, Placebo-Controlled Study.

Dougados M, van der Heijde D, Sieper J, Braun J, Citera G, Lenaerts J, van den Bosch F, Wei JC, Pedersen R, Bonin R, Jones H, Marshall L, Logeart I, Vlahos B, Bukowski JF, Maksymowych WP.

Arthritis Care Res (Hoboken). 2017 Oct;69(10):1590-1598. doi: 10.1002/acr.23276. Epub 2017 Aug 31.

7.

Database-Centric Method for Automated High-Throughput Deconvolution and Analysis of Kinetic Antibody Screening Data.

Nobrega RP, Brown M, Williams C, Sumner C, Estep P, Caffry I, Yu Y, Lynaugh H, Burnina I, Lilov A, Desroches J, Bukowski J, Sun T, Belk JP, Johnson K, Xu Y.

SLAS Technol. 2017 Oct;22(5):547-556. doi: 10.1177/2472630317705611. Epub 2017 Apr 21.

PMID:
28430560
8.

Dr. Wiland, et al, reply.

Wiland P, Dudler J, Veale D, Tahir H, Pedersen R, Bukowski J, Vlahos B, Williams T, Gaylord S, Kotak S.

J Rheumatol. 2017 Feb;44(2):259. doi: 10.3899/jrheum.161405. No abstract available.

PMID:
28148758
9.

Validation of Autoclave Protocols for Successful Decontamination of Category A Medical Waste Generated from Care of Patients with Serious Communicable Diseases.

Garibaldi BT, Reimers M, Ernst N, Bova G, Nowakowski E, Bukowski J, Ellis BC, Smith C, Sauer L, Dionne K, Carroll KC, Maragakis LL, Parrish NM.

J Clin Microbiol. 2017 Feb;55(2):545-551. doi: 10.1128/JCM.02161-16. Epub 2016 Dec 7.

10.

The Effect of Reduced or Withdrawn Etanercept-methotrexate Therapy on Patient-reported Outcomes in Patients with Early Rheumatoid Arthritis.

Wiland P, Dudler J, Veale D, Tahir H, Pedersen R, Bukowski J, Vlahos B, Williams T, Gaylord S, Kotak S.

J Rheumatol. 2016 Jul;43(7):1268-77. doi: 10.3899/jrheum.151179. Epub 2016 Jun 1.

PMID:
27252426
11.

Two-year Efficacy and Safety of Etanercept in Pediatric Patients with Extended Oligoarthritis, Enthesitis-related Arthritis, or Psoriatic Arthritis.

Constantin T, Foeldvari I, Vojinovic J, Horneff G, Burgos-Vargas R, Nikishina I, Akikusa JD, Avcin T, Chaitow J, Koskova E, Lauwerys BR, Calvo Penades I, Flato B, Gamir ML, Huppertz HI, Jaller Raad JJ, Jarosova K, Anton J, Macku M, Otero Escalante WJ, Rutkowska-Sak L, Trauzeddel R, Velez-Sanchez PJ, Wouters C, Wajdula J, Zang C, Bukowski J, Woodworth D, Vlahos B, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

J Rheumatol. 2016 Apr;43(4):816-24. doi: 10.3899/jrheum.150430. Epub 2016 Mar 1.

PMID:
26932344
12.

Commercial Airline In-Flight Emergency: Medical Student Response and Review of Medicolegal Issues.

Bukowski JH, Richards JR.

J Emerg Med. 2016 Jan;50(1):74-8. doi: 10.1016/j.jemermed.2015.09.026. Epub 2015 Oct 26.

PMID:
26514306
13.

Evaluation of Health Outcomes with Etanercept Treatment in Patients with Early Nonradiographic Axial Spondyloarthritis.

Dougados M, Tsai WC, Saaibi DL, Bonin R, Bukowski J, Pedersen R, Vlahos B, Kotak S.

J Rheumatol. 2015 Oct;42(10):1835-41. doi: 10.3899/jrheum.141313. Epub 2015 Aug 15.

PMID:
26276968
14.

Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study.

Maksymowych WP, Dougados M, van der Heijde D, Sieper J, Braun J, Citera G, Van den Bosch F, Logeart I, Wajdula J, Jones H, Marshall L, Bonin R, Pedersen R, Vlahos B, Kotak S, Bukowski JF.

Ann Rheum Dis. 2016 Jul;75(7):1328-35. doi: 10.1136/annrheumdis-2015-207596. Epub 2015 Aug 12.

15.

Evaluation of the effect of tofacitinib on measured glomerular filtration rate in patients with active rheumatoid arthritis: results from a randomised controlled trial.

Kremer JM, Kivitz AJ, Simon-Campos JA, Nasonov EL, Tony HP, Lee SK, Vlahos B, Hammond C, Bukowski J, Li H, Schulman SL, Raber S, Zuckerman A, Isaacs JD.

Arthritis Res Ther. 2015 Apr 6;17:95. doi: 10.1186/s13075-015-0612-7.

16.

The burden of non-radiographic axial spondyloarthritis.

Boonen A, Sieper J, van der Heijde D, Dougados M, Bukowski JF, Valluri S, Vlahos B, Kotak S.

Semin Arthritis Rheum. 2015 Apr;44(5):556-562. doi: 10.1016/j.semarthrit.2014.10.009. Epub 2014 Oct 22. Review.

PMID:
25532945
17.

Sustained remission with etanercept tapering in early rheumatoid arthritis.

Emery P, Hammoudeh M, FitzGerald O, Combe B, Martin-Mola E, Buch MH, Krogulec M, Williams T, Gaylord S, Pedersen R, Bukowski J, Vlahos B.

N Engl J Med. 2014 Nov 6;371(19):1781-92. doi: 10.1056/NEJMoa1316133.

18.

Inactivation of a GAL4-like transcription factor improves cell fitness and product yield in glycoengineered Pichia pastoris strains.

Jiang B, Argyros R, Bukowski J, Nelson S, Sharkey N, Kim S, Copeland V, Davidson RC, Chen R, Zhuang J, Sethuraman N, Stadheim TA.

Appl Environ Microbiol. 2015 Jan;81(1):260-71. doi: 10.1128/AEM.02619-14. Epub 2014 Oct 24.

19.

Evaluation of levonorgestrel intrauterine system upon presumed nonintact removal.

Bukowski J, Rogers A, Cansino C.

Am J Obstet Gynecol. 2014 Dec;211(6):e1-2. doi: 10.1016/j.ajog.2014.09.004. Epub 2014 Sep 9.

PMID:
25218958
20.

Critical review of the epidemiologic literature regarding the association between congenital heart defects and exposure to trichloroethylene.

Bukowski J.

Crit Rev Toxicol. 2014 Aug;44(7):581-9. doi: 10.3109/10408444.2014.910755. Epub 2014 Jun 5. Review.

PMID:
24898789
21.

Symptomatic efficacy of etanercept and its effects on objective signs of inflammation in early nonradiographic axial spondyloarthritis: a multicenter, randomized, double-blind, placebo-controlled trial.

Dougados M, van der Heijde D, Sieper J, Braun J, Maksymowych WP, Citera G, Miceli-Richard C, Wei JC, Pedersen R, Bonin R, Rahman MU, Logeart I, Wajdula J, Koenig AS, Vlahos B, Alvarez D, Bukowski JF.

Arthritis Rheumatol. 2014 Aug;66(8):2091-102. doi: 10.1002/art.38721.

22.

shRNA screening identifies JMJD1C as being required for leukemia maintenance.

Sroczynska P, Cruickshank VA, Bukowski JP, Miyagi S, Bagger FO, Walfridsson J, Schuster MB, Porse B, Helin K.

Blood. 2014 Mar 20;123(12):1870-82. doi: 10.1182/blood-2013-08-522094. Epub 2014 Feb 5.

23.

Extreme sensitivity and the practical implications of risk assessment thresholds.

Bukowski J, Nicolich M, Lewis RJ.

Dose Response. 2012 Mar 19;11(2):130-53. doi: 10.2203/dose-response.12-002.Lewis. Print 2013.

24.

Production of sialylated O-linked glycans in Pichia pastoris.

Hamilton SR, Cook WJ, Gomathinayagam S, Burnina I, Bukowski J, Hopkins D, Schwartz S, Du M, Sharkey NJ, Bobrowicz P, Wildt S, Li H, Stadheim TA, Nett JH.

Glycobiology. 2013 Oct;23(10):1192-203. doi: 10.1093/glycob/cwt056. Epub 2013 Jul 26.

PMID:
23893788
25.

Characterization of the Pichia pastoris protein-O-mannosyltransferase gene family.

Nett JH, Cook WJ, Chen MT, Davidson RC, Bobrowicz P, Kett W, Brevnova E, Potgieter TI, Mellon MT, Prinz B, Choi BK, Zha D, Burnina I, Bukowski JT, Du M, Wildt S, Hamilton SR.

PLoS One. 2013 Jul 1;8(7):e68325. doi: 10.1371/journal.pone.0068325. Print 2013.

26.

Comment on: "Visual contrast sensitivity in children exposed to tetrachloroethylene" by Storm et al.

Bukowski J.

Arch Environ Occup Health. 2012;67(1):51-2; author reply 53-5. doi: 10.1080/19338244.2011.646362. No abstract available.

PMID:
22315937
27.

Review of the epidemiologic literature on residential exposure to perchloroethylene.

Bukowski JA.

Crit Rev Toxicol. 2011 Oct;41(9):771-82. doi: 10.3109/10408444.2011.581649. Epub 2011 Jul 5. Review.

PMID:
21728756
28.

Arabidopsis genes IRREGULAR XYLEM (IRX15) and IRX15L encode DUF579-containing proteins that are essential for normal xylan deposition in the secondary cell wall.

Brown D, Wightman R, Zhang Z, Gomez LD, Atanassov I, Bukowski JP, Tryfona T, McQueen-Mason SJ, Dupree P, Turner S.

Plant J. 2011 May;66(3):401-13. doi: 10.1111/j.1365-313X.2011.04501.x. Epub 2011 Feb 24.

29.

JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells.

Pasini D, Cloos PA, Walfridsson J, Olsson L, Bukowski JP, Johansen JV, Bak M, Tommerup N, Rappsilber J, Helin K.

Nature. 2010 Mar 11;464(7286):306-10. doi: 10.1038/nature08788.

PMID:
20075857
30.

Radiographic severity of knee osteoarthritis is conditional on interleukin 1 receptor antagonist gene variations.

Attur M, Wang HY, Kraus VB, Bukowski JF, Aziz N, Krasnokutsky S, Samuels J, Greenberg J, McDaniel G, Abramson SB, Kornman KS.

Ann Rheum Dis. 2010 May;69(5):856-61. doi: 10.1136/ard.2009.113043. Epub 2009 Nov 23.

31.

Epidemiologic evidence for chloroprene carcinogenicity: review of study quality and its application to risk assessment.

Bukowski JA.

Risk Anal. 2009 Sep;29(9):1203-16. doi: 10.1111/j.1539-6924.2009.01254.x. Epub 2009 Jun 24. Review.

PMID:
19558388
32.

Standardized capsule of Camellia sinensis lowers cardiovascular risk factors in a randomized, double-blind, placebo-controlled study.

Nantz MP, Rowe CA, Bukowski JF, Percival SS.

Nutrition. 2009 Feb;25(2):147-54. doi: 10.1016/j.nut.2008.07.018. Epub 2008 Oct 9.

PMID:
18848434
33.

L-theanine intervention enhances human gammadeltaT lymphocyte function.

Bukowski JF, Percival SS.

Nutr Rev. 2008 Feb;66(2):96-102. doi: 10.1111/j.1753-4887.2007.00013.x. Review.

PMID:
18254876
34.

Do pollution time-series studies contain uncontrolled or residual confounding by risk factors for acute health events?

Bukowski J.

Regul Toxicol Pharmacol. 2008 Jul;51(2):135-40. doi: 10.1016/j.yrtph.2007.12.003. Epub 2007 Dec 15.

PMID:
18207297
35.

Bioactive food components that enhance gammadelta T cell function may play a role in cancer prevention.

Percival SS, Bukowski JF, Milner J.

J Nutr. 2008 Jan;138(1):1-4. Review.

PMID:
18156395
36.

Do time-series studies contain residual confounding by risk factors for acute health events?

Bukowski J.

Epidemiology. 2007 Nov;18(6):839. No abstract available.

PMID:
18049199
37.

Culture of C3A cells in alginate beads for fluidized bed bioartificial liver.

Kinasiewicz A, Gautier A, Lewinska D, Bukowski J, Legallais C, Weryński A.

Transplant Proc. 2007 Nov;39(9):2911-3.

PMID:
18022014
39.

Interactions between subunits of Saccharomyces cerevisiae RNase MRP support a conserved eukaryotic RNase P/MRP architecture.

Aspinall TV, Gordon JM, Bennett HJ, Karahalios P, Bukowski JP, Walker SC, Engelke DR, Avis JM.

Nucleic Acids Res. 2007;35(19):6439-50. Epub 2007 Sep 19.

40.

Evaluating emerging issues in epidemiology.

Collins JJ, Bukowski JA, Weed DL, Brent RL, Klein P, Boerstoel-Streefland M, Sprafka JM, Williams AL, Holsapple MP.

Regul Toxicol Pharmacol. 2007 Aug;48(3):296-307. Epub 2007 Apr 14.

PMID:
17543434
41.

Osteoporosis management in patients with rheumatoid arthritis: Evidence for improvement.

Solomon DH, Katz JN, Cabral D, Patrick AR, Bukowski JF, Coblyn JS.

Arthritis Rheum. 2006 Dec 15;55(6):873-7.

42.

GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow.

Guan X, Karpen HE, Stephens J, Bukowski JT, Niu S, Zhang G, Stoll B, Finegold MJ, Holst JJ, Hadsell D, Nichols BL, Burrin DG.

Gastroenterology. 2006 Jan;130(1):150-64. Erratum in: Gastroenterology. 2006 Mar;130(3):1019-21. Hadsell, Darry L [corrected to Hadsell, Darryl].

PMID:
16401478
43.

Alternative bisphosphonate targets and mechanisms of action.

Bukowski JF, Dascher CC, Das H.

Biochem Biophys Res Commun. 2005 Mar 18;328(3):746-50. Review.

PMID:
15694409
44.

Association between air pollution and adverse pregnancy outcomes in Vancouver.

Bukowski JA.

Environ Health Perspect. 2004 Oct;112(14):A792; author reply A792-4. No abstract available.

45.

Identification of guinea pig gammadelta T cells and characterization during pulmonary tuberculosis.

Xiong X, Morita CT, Bukowski JF, Brenner MB, Dascher CC.

Vet Immunol Immunopathol. 2004 Nov;102(1-2):33-44.

PMID:
15451613
46.

Practical implications of nonlinear effects in risk-assessment harmonization.

Bukowski JA, Lewis RJ.

Nonlinearity Biol Toxicol Med. 2004 Jan;2(1):3-10. doi: 10.1080/15401420490426927.

47.

Review of respiratory morbidity from occupational exposure to oil mists.

Bukowski JA.

Appl Occup Environ Hyg. 2003 Nov;18(11):828-37.

PMID:
14555435
48.

An analysis of the risk of B-lymphocyte malignancies in industrial cohorts.

Bukowski JA, Huebner WW, Schnatter AR, Wojcik NC.

J Toxicol Environ Health A. 2003 Apr 11;66(7):581-97. Review.

PMID:
12751389
49.

Antigens in tea-beverage prime human Vgamma 2Vdelta 2 T cells in vitro and in vivo for memory and nonmemory antibacterial cytokine responses.

Kamath AB, Wang L, Das H, Li L, Reinhold VN, Bukowski JF.

Proc Natl Acad Sci U S A. 2003 May 13;100(10):6009-14. Epub 2003 Apr 28.

50.

Is the hygiene hypothesis an example of hormesis?

Bukowski JA, Lewis RJ.

Nonlinearity Biol Toxicol Med. 2003 Apr;1(2):155-66.

Supplemental Content

Loading ...
Support Center